Hemostasis Today

May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS
May 22, 2026, 08:45

Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS

Dirk Sibbing, Cardiologist and Angiologist at Lauterbacher Mill Private Clinic and LMU Munich, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Heart Journal, adding:

”In this large-scale meta-analysis encompassing more than 30,000 patients and led by Claudio Laudani we report on significant interactions of ethnicity with treatment effects of SAPT (ASS vs. Clopidogrel) on MACE in CCS patients.

Again, data pointing towards more personalized approaches of antiplatelet treatment in patients with coronary artery disease.

We urgently need a large-scale multi-ethnic trial to sort this out…

Just published and online ahead of print in the European Heart Journal.”

Title: Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences Get access Arrow

Authors: Claudio Laudani, Giovanni Occhipinti, Francesco Costa, Domenico D’Amario, Tullio Palmerini, Sebastiano Sciarretta, Charles Michael Gibson, Behnood Bikdeli, Felicita Andreotti, Young-Hoon Jeong, Takeshi Kimura, Diana A. Gorog, Dirk Sibbing, Davide Capodanno, Jurrien ten Berg, Raffaele De Caterina, Mattia Galli

Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS

Stay updated on all scientific advances with Hemostasis Today.